Related Tags >> ImClone Erbitux Phase III FDA

head and neck cancer News

Most Popular head and neck cancer Story

Abigail Alliance v. Von Eschenbach: A closer look

August 10, 2007 — 6:59am ET

Abigail Alliance v. Von Eschenbach: A closer look In 2003, the Abigail Alliance for Better Access to Developmental Drugs sued the FDA to gain greater access to unapproved... Read more...

Latest Headlines

Introgen gets positive Phase III Advexin data
April 15, 2008
ALSO NOTED: Meda buys late-stage drugs;Debiopharm licenses peptide;and much more...
April 14, 2008
Genzyme to collaborate on gene therapy in China
October 26, 2007
Introgen reports biomarker link to new therapy
September 27, 2007
ALSO NOTED: Vernalis reports "striking" weight loss in trial; Genmab shares surge on Phase III; FDA wants more time on Entereg;
September 13, 2007
Abigail Alliance v. Von Eschenbach: A closer look
August 10, 2007
ALSO NOTED: Vasogen gets direction on Celacade: EndoCeutics pulls IPO; Ventana cool to bid; and much more...
June 27, 2007
CEL-SCI blueprints new manufacturing plant
January 22, 2007
FDA approves Taxotere for head, neck cancer
October 17, 2006
Cytokinetics' ispinesip flunks another trial
October 2, 2006
YM BioSciences gains $14.5M up front in licensing deal
July 30, 2006
Sanofi inks $360M in cancer pact
July 4, 2006
Erbitux approved for head and neck cancers
March 1, 2006
ImClone touts increased survival rate in Erbitux cancer trial
November 15, 2005
SPOTLIGHT: ImClone pushes new indication
June 19, 2005
Erbitux effective in cancer trial
June 7, 2005

Paid Research Reports